In a minority of patients (5/100; 5%) mutations in addition to BCR::ABL1 persisted over all time points analyzed and therefore seem to precede the BCR::ABL1 translocation indicating a multistep pathogenesis in CML as suggested previously [6, 41, 42]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.